Home2315 • HKG
add
Biocytogen Pharmaceuticals Beijng Co Ltd
Previous close
$6.25
Day range
$6.17 - $7.00
Year range
$5.74 - $15.60
Market cap
2.79B HKD
Avg Volume
214.60K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 205.25M | 25.60% |
Operating expense | 152.22M | -22.45% |
Net income | -25.34M | 73.30% |
Net profit margin | -12.34 | 78.75% |
Earnings per share | — | — |
EBITDA | 46.50M | 228.84% |
Effective tax rate | -7.64% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 419.85M | -26.19% |
Total assets | 2.43B | -10.51% |
Total liabilities | 1.69B | -3.70% |
Total equity | 744.24M | — |
Shares outstanding | 399.40M | — |
Price to book | 3.38 | — |
Return on assets | 0.39% | — |
Return on capital | 0.71% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -25.34M | 73.30% |
Cash from operations | 14.80M | 268.52% |
Cash from investing | -15.98M | 64.49% |
Cash from financing | -6.73M | -162.60% |
Net change in cash | -6.88M | 81.93% |
Free cash flow | 31.15M | 151.66% |
About
Founded
Nov 13, 2009
Website
Employees
1,040
